Summary
This study examined the question of whether previous exposure to cytostatic drugs by oncology nurses was sufficient to lead to haematological phenotypical subclinical abnormalities which had previously been identified in a population of patients who had received chemotherapy as an adjuvant to breast surgery. A comparison of baseline haematological parameters, and the results of a prednisolone stimulation test, was made between nurses regularly coming into contact with such agents and an age-adjusted group of nurses who had not been exposed. Although there is a persistent trend toward lower neutrophils, platelets, monocytes and neutrophil reserves in the nurses who handled antineoplastic agents, a statistically significant decrement in these parameters was not identified. Such a finding should help to reassure individuals who have had similar exposure, but does not negate the importance of following published recommended guidelines for the handling and dispensing of antineoplastic agents.
Similar content being viewed by others
References
Corder MP, Jochimsen PR. Marrow neutrophil reserve after adjuvant chemotherapy for cancer of the breast. Cancer 49: 2455–2458, 1981
Council on Scientifíc Affairs. Guidelines for handling parenteral antineoplastics. Journal of the American Medical Association 253: 1590–1592, 1985
Cream JJ. Prednisolone induced granulocytosis. British Journal of Haematology 15: 259–267, 1968
Falck K, Grohn P, Sorsa M, et al. Mutagenicity in urine or nurses handling systolic drugs. Lancet 1: 1250–1251, 1979
Goodyear MOE, Mackay IR, Russell IS. Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer. Cancer, Chemotherapy and Pharmacology 7: 37–40, 1981
Jordan DK, Patil SR, Jochimsen PR, Lachenbruch PA, Corder MP. Sister chromatid exchange analysis in nurses handling antineoplastic drugs. Cancer Investigation 4: 101–107, 1986
Selevan SG, Lindbohm M, Sci CP, Hornung RW, Hemminke K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine 313: 1173–1178, 1985
Stellman JM, Zoloth SR. Cancer chemotherapeutic agents as occupational hazards: a literature review. Cancer Investigation 4(2): 127–135, 1986
Venitt S, Croften-Sleigh C, Hunt J, Speechley N, Buggs K. Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet 1: 74–77, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jochimsen, P.R., Corder, M.P., Lachenbruch, P.A. et al. Preparation and Administration of Chemotherapy. Dis-Manage-Health-Outcomes 3, 59–63 (1988). https://doi.org/10.1007/BF03259931
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259931